Eventide Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$46.7M |
| 2 |
iRhythm Holdings
IRTC
|
+$37M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$35.8M |
| 4 |
Entegris
ENTG
|
+$21.4M |
| 5 |
Global E Online
GLBE
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Transmedics
TMDX
|
+$70.1M |
| 2 |
Trane Technologies
TT
|
+$69.4M |
| 3 |
Datadog
DDOG
|
+$63.8M |
| 4 |
argenx
ARGX
|
+$56M |
| 5 |
GitLab
GTLB
|
+$46.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.6% |
| 2 | Technology | 18.78% |
| 3 | Industrials | 17.39% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Financials | 2.63% |
Similar funds
Eventide Asset Management's Q3 2024 Portfolio in Review
As of Q3 2024, Eventide Asset Management held 197 positions worth $5.8B, down 0.69% from $5.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Eventide Asset Management withdrew a net $460M in Q3 2024, closing 17 positions and reducing 55 holdings. Its most notable exit was Nextpower Inc, an estimated $36.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.
Against the trend, Eventide Asset Management opened a new position in Relay Therapeutics worth $19M.
- Eventide Asset Management's largest Q3 2024 buy was Relay Therapeutics: 2,682,083 shares worth $19M.
- Eventide Asset Management added most to Verona Pharma in Q3 2024, an estimated $46.7M increase.
- Eventide Asset Management's biggest Q3 2024 reduction was Transmedics, cutting an estimated $70.1M.
- Eventide Asset Management fully exited Nextpower Inc in Q3 2024, selling an estimated $36.6M.
- Eventide Asset Management's ten largest holdings make up 25% of its $5.8B portfolio in Q3 2024.
- Eventide Asset Management opened 37 new positions and closed 17 in Q3 2024.
- Eventide Asset Management's portfolio value fell 0.69% quarter-over-quarter to $5.8B.
Based on Eventide Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.